oocyte

Overview

An oocyte is the female germ cell, or egg cell, produced in the ovary and capable of being fertilized by sperm to form a zygote. It is central to sexual reproduction and early embryonic development, and its biological quality strongly influences fertilization success, embryo viability, and reproductive lifespan. In biomedical research, oocytes are often studied as a model for female fertility, ovarian aging, mitochondrial function, oxidative stress, and the effects of metabolic or environmental insults on reproductive potential.

Oocytes are also important in experimental reproductive biology because they can be manipulated by assisted reproductive technologies, in vitro maturation, in vitro fertilization, embryo transfer, and gene-editing approaches such as CRISPR-Cas method and CRISPR-Cas12a. Recent studies have used oocytes to investigate how aging, diabetes, and oxidative stress affect developmental competence, and how interventions may preserve oocyte quality or enable precise genetic modification in embryos and germline cells.

Focus of Latest Publications

Recent publications on oocyte biology have focused on reproductive aging, metabolic stress, and experimental manipulation of germ cells. In a mouse study of ovarian aging, oocytes were examined alongside ovarian somatic cells across age groups, with reproductive function assessed by superovulation, in vitro fertilization, and embryo transfer. The work found that age-related p16 upregulation occurred prominently in cumulus, granulosa, and theca cells, but not in oocytes or blastocysts, suggesting that somatic cell senescence rather than direct p16 changes in oocytes correlated more closely with declining reproductive function and poorer post-implantation outcomes.

Another study addressed oocyte quality under diabetic conditions. In vitro matured oocytes from type 1 diabetic mice were supplemented with BGP-15 during maturation, which improved maturation rates and reduced oxidative stress, mitochondrial damage, and DNA damage. Transcriptome analysis linked the diabetic effect on oocytes mainly to dysregulated metabolism and mitochondrial-related pathways, and the authors reported that BGP-15 increased mitochondrial fatty acid β-oxidation, supporting a protective role for this compound in preserving oocyte competence under maternal diabetes-related stress.

Oocytes were also used as a target in a methodological study of genome editing in reptiles. Researchers developed a surgical approach in brown anole lizards that allowed access to unfertilized oocytes still maturing within the ovary, followed by microinjection of CRISPR-Cas9 ribonucleoprotein complexes. This enabled targeted mutagenesis despite the practical barriers posed by internal fertilization and difficulty identifying ovulation, demonstrating a route for routine gene-edited lizard production.

In addition, recent review literature has highlighted oocytes as a key experimental system in reproductive genome editing. A broader discussion of CRISPR/Cas9 in reproductive failure described the use of oocytes and zygotes for disease modeling and proof-of-concept editing studies, while emphasizing technical barriers such as off-target effects, embryo mosaicism, and low homology-directed repair efficiency. Together, these publications show oocytes being studied both as a biologically vulnerable cell type in aging and disease and as an important platform for reproductive biotechnology.